Abstract

Conventional skin and blood sampling techniques for disease diagnosis, though effective, are often highly invasive and some even suffer from variations in analysis. With the improvements in molecular detection, the amount of starting sample quantity needed has significantly reduced in some diagnostic procedures, and this has led to an increased interest in microsampling techniques for disease biomarker detection. The miniaturization of sampling platforms driven by microsampling has the potential to shift disease diagnosis and monitoring closer to the point of care. The faster turnaround time for actionable results has improved patient care. The variations in sample quantification and analysis remain a challenge in the microsampling field. The future of microsampling looks promising. Emerging techniques are being clinically tested and monitored by regulatory bodies. This process is leading to safer and more reliable diagnostic platforms. This review discusses the advantages and disadvantages of current skin and blood microsampling techniques.

Highlights

  • Microsampling is a procedure for capturing minute samples from human body for analysis in a minimally invasive manner

  • An approach that bridges the gap between small blood sampling and analysis is dried blood spot (DBS)

  • Volumetric absorptive microsampling (VAMS) is a novel approach that permits the collection of a fixed volume of whole blood

Read more

Summary

Introduction

Microsampling is a procedure for capturing minute samples (usually

Blood microsampling
Dried blood spot
81 Page 4 of 30
Plasma microsampling
Volumetric absorptive microsampling
81 Page 8 of 30
Microneedle
81 Page 10 of 30
81 Page 12 of 30
Conventional and invasive skin sampling techniques
Abrasion techniques
81 Page 14 of 30
Tape stripping
81 Page 16 of 30
Fractional skin harvesting
Reverse iontophoresis
81 Page 18 of 30
81 Page 20 of 30
Nanopores
Saliva
81 Page 22 of 30
Microsampling
Business model of current diagnostic market
Impacts of a decentralized business model on other stakeholders
Challenges in microsampling
81 Page 26 of 30
The commercialization of a microsampling platform
The future of diagnostic field
81 Page 28 of 30
Findings
81 Page 30 of 30
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.